2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $809M | $650M | $907M | $936M | $1B |
Cost of Revenue | $526M | $429M | $591M | $594M | $666M |
Gross Profit | $283M | $220M | $316M | $342M | $348M |
Gross Profit % | 35% | 34% | 35% | 37% | 34% |
R&D Expenses | $11M | $12M | $15M | $21M | $26M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $60M | $9.1M | $30M | $48M | $47M |
Dep. & Amort. | $29M | $28M | $42M | $42M | $46M |
Def. Tax | $7.4M | -$8.7M | -$2M | -$300K | -$15M |
Stock Comp. | $4.5M | $8M | $11M | $10M | $12M |
Chg. in WC | -$4.1M | $37M | -$57M | -$26M | -$37M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $114M | $202M | $115M | $133M | $114M |
ST Investments | $0 | $0 | $859K | $7.6M | $0 |
Cash & ST Inv. | $114M | $202M | $115M | $133M | $114M |
Receivables | $124M | $105M | $148M | $151M | $171M |
Inventory | $127M | $111M | $172M | $179M | $186M |
Columbus McKinnon (CMCO) announced a transformational acquisition of Keto Crosby, expected to double the company's size and enhance its market position, with $70 million in net cost synergies anticipated by the end of year three.
Fiscal year 2025 guidance includes a mid-single-digit sales decrease year-over-year, a low-teens decline in adjusted EPS, and CapEx between $18 million to $22 million, with a net leverage ratio of approximately 3x by year-end.
Third-quarter results showed an 8% year-over-year decline in net sales to $234.1 million, driven by weaker short-cycle demand and economic softness in Europe, with adjusted EBITDA at $37.8 million and a margin of 16.1%.
The acquisition is expected to be accretive to adjusted EPS in the first year post-closing and will generate over $200 million in annual free cash flow, enabling rapid deleveraging and reinvestment in growth.
Keto Crosby's addition brings a complementary product portfolio, geographic diversification, and exposure to industry megatrends like near-shoring and automation, with a pro forma adjusted EBITDA margin of 23%.